12:00 AM
Aug 21, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Synthetic Type II collagen telopeptide sequences regulatory update

OSTX received U.S. Patent No. 6,100,379 covering methods for quantifying cross-linked telopeptides produced in vivo upon...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >